Publications 2021
Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.
Haematologica 107(7), 1577-1588 (2021) [10.3324/haematol.2021.278952]
BibTeX |
EndNote:
XML,
Text |
RIS
A Basic Treatment of the Distance Covariance
Sankhya? / B 83(S1), 12 - 25 (2021) [10.1007/s13571-021-00248-z]
BibTeX |
EndNote:
XML,
Text |
RIS
Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients
Clinical epigenetics 13(1), 207 (2021) [10.1186/s13148-021-01196-1]
BibTeX |
EndNote:
XML,
Text |
RIS
Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial.
ESMO open 6(6), 100310 (2021) [10.1016/j.esmoop.2021.100310]
BibTeX |
EndNote:
XML,
Text |
RIS
Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the Prognosis.
Frontiers in oncology 11, 757664 (2021) [10.3389/fonc.2021.757664]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Deep learning can predict lymph node status directly from histology in colorectal cancer.
European journal of cancer 157, 464 - 473 (2021) [10.1016/j.ejca.2021.08.039]
BibTeX |
EndNote:
XML,
Text |
RIS
Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial.
Cancers 13(19), 4856 (2021) [10.3390/cancers13194856]
BibTeX |
EndNote:
XML,
Text |
RIS
Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated.
Journal of clinical oncology 39(34), 3839-3852 (2021) [10.1200/JCO.21.00784]
BibTeX |
EndNote:
XML,
Text |
RIS
Local ablative treatment with surgery and/or radiotherapy in single-site and oligometastatic carcinoma of unknown primary.
European journal of cancer 157, 179 - 189 (2021) [10.1016/j.ejca.2021.08.019]
BibTeX |
EndNote:
XML,
Text |
RIS
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma.
Cancers 13(18), 4706 (2021) [10.3390/cancers13184706]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
The prognostic significance of [18F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs).
EJNMMI Research 11(1), 100 (2021) [10.1186/s13550-021-00846-y]
BibTeX |
EndNote:
XML,
Text |
RIS
Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia.
Nature Communications 12(1), 5395 (2021) [10.1038/s41467-021-25403-y]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Super-enhancer-based identification of a BATF3/IL-2R?module reveals vulnerabilities in anaplastic large cell lymphoma
Nature Communications 12(1), 5577 (2021) [10.1038/s41467-021-25379-9]
BibTeX |
EndNote:
XML,
Text |
RIS
GTF2I Mutation in Thymomas: Independence From Racial-Ethnic Backgrounds. An Indian/German Comparative Study.
Pathology & oncology research 27, 1609858 (2021) [10.3389/pore.2021.1609858]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Assessment of early metabolic progression in melanoma patients under immunotherapy: an 18F-FDG PET/CT study.
EJNMMI Research 11(1), 89 (2021) [10.1186/s13550-021-00832-4]
BibTeX |
EndNote:
XML,
Text |
RIS
A microRNA panel compared to environmental and polygenic scores for colorectal cancer risk prediction.
Nature Communications 12(1), 4811 (2021) [10.1038/s41467-021-25067-8]
BibTeX |
EndNote:
XML,
Text |
RIS
The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets.
Cancer discovery 11(11), 2764-2779 (2021) [10.1158/2159-8290.CD-21-0094]
BibTeX |
EndNote:
XML,
Text |
RIS
Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: results from a large cohort of patients with long follow-up.
British journal of haematology 195(2), 230-243 (2021) [10.1111/bjh.17685]
BibTeX |
EndNote:
XML,
Text |
RIS
Antibiotic Prophylaxis or Granulocyte-Colony Stimulating Factor Support in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.
Cancers 13(14), 3439 (2021) [10.3390/cancers13143439]
BibTeX |
EndNote:
XML,
Text |
RIS
Consistent Major Differences in Sex- and Age-Specific Diagnostic Performance among Nine Faecal Immunochemical Tests Used for Colorectal Cancer Screening.
Cancers 13(14), 3574 - (2021) [10.3390/cancers13143574]
BibTeX |
EndNote:
XML,
Text |
RIS
The coding microsatellite mutation profile of PMS2-deficient colorectal cancer.
Experimental and molecular pathology 122, 104668 (2021) [10.1016/j.yexmp.2021.104668]
BibTeX |
EndNote:
XML,
Text |
RIS
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer.
Cell reports 36(3), 109394 (2021) [10.1016/j.celrep.2021.109394]
BibTeX |
EndNote:
XML,
Text |
RIS
EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients
Frontiers in immunology 12, 634416 (2021) [10.3389/fimmu.2021.634416]
BibTeX |
EndNote:
XML,
Text |
RIS
Basophils balance healing after myocardial infarction via IL-4/IL-13.
The journal of clinical investigation 131(13), e136778 (2021) [10.1172/JCI136778]
BibTeX |
EndNote:
XML,
Text |
RIS
The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma.
Scientific reports 11(1), 10926 (2021) [10.1038/s41598-021-90381-6]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Improvement of PI-RADS-dependent prostate cancer classification by quantitative image assessment using radiomics or mean ADC.
Magnetic resonance imaging 82, 9-17 (2021) [10.1016/j.mri.2021.06.013]
BibTeX |
EndNote:
XML,
Text |
RIS
Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients.
Haematologica 106(10), 2754-2758 (2021) [10.3324/haematol.2021.278888]
BibTeX |
EndNote:
XML,
Text |
RIS
Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1 mutated acute myeloid leukemia receiving gemtuzumab ozogamicin.
Haematologica 106(11), 2986-2989 (2021) [10.3324/haematol.2021.278894]
BibTeX |
EndNote:
XML,
Text |
RIS
Fully Automatic Deep Learning in Bi-institutional Prostate Magnetic Resonance Imaging: Effects of Cohort Size and Heterogeneity.
Investigative radiology 56(12), 799-808 (2021) [10.1097/RLI.0000000000000791]
BibTeX |
EndNote:
XML,
Text |
RIS
Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial.
Leukemia 35(10), 3007-3011 (2021) [10.1038/s41375-021-01298-y]
BibTeX |
EndNote:
XML,
Text |
RIS
HIF1?-mediated RelB/APOBEC3B downregulation allows Hepatitis B Virus persistence.
Hepatology 74(4), 1766-1781 (2021) [10.1002/hep.31902]
BibTeX |
EndNote:
XML,
Text |
RIS
Author Correction: Methods and open-source toolkit for analyzing and visualizing challenge results.
Scientific reports 11(1), 10144 (2021) [10.1038/s41598-021-88636-3]
BibTeX |
EndNote:
XML,
Text |
RIS
Heidelberg colorectal data set for surgical data science in the sensor operating room.
Scientific data 8(1), 101 (2021) [10.1038/s41597-021-00882-2]
BibTeX |
EndNote:
XML,
Text |
RIS
Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21
American journal of hematology 96(7), E253-E257 (2021) [10.1002/ajh.26191]
BibTeX |
EndNote:
XML,
Text |
RIS
Efficacy and Safety of Checkpoint Inhibitor Treatment in Patients with Advanced Renal or Urothelial Cell Carcinoma and Concomitant Chronic Kidney Disease: A Retrospective Cohort Study
Cancers 13(7), 1623 (2021) [10.3390/cancers13071623]
BibTeX |
EndNote:
XML,
Text |
RIS
Quantitative Dynamic 18F-FDG PET/CT in Survival Prediction of Metastatic Melanoma under PD-1 Inhibitors.
Cancers 13(5), 1019 (2021) [10.3390/cancers13051019]
BibTeX |
EndNote:
XML,
Text |
RIS
Predicting the Risk of Metastases by PSMA-PET/CT-Evaluation of 335 Men with Treatment-Naïve Prostate Carcinoma.
Cancers 13(7), 1508 (2021) [10.3390/cancers13071508]
BibTeX |
EndNote:
XML,
Text |
RIS
TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma.
Acta neuropathologica 141(6), 959-970 (2021) [10.1007/s00401-021-02300-8]
BibTeX |
EndNote:
XML,
Text |
RIS
Analyzing Longitudinal wb-MRI Data and Clinical Course in a Cohort of Former Smoldering Multiple Myeloma Patients: Connections between MRI Findings and Clinical Progression Patterns
Cancers 13(5), 961 (2021) [10.3390/cancers13050961]
BibTeX |
EndNote:
XML,
Text |
RIS
Selective elimination of immunosuppressive T cells in patients with multiple myeloma.
Leukemia 35(9), 2602-2615 (2021) [10.1038/s41375-021-01172-x]
BibTeX |
EndNote:
XML,
Text |
RIS
Performance of [68Ga]Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer after prostatectomy-a multi-centre evaluation of 2533 patients.
European journal of nuclear medicine and molecular imaging 48(9), 2925-2934 (2021) [10.1007/s00259-021-05189-3]
BibTeX |
EndNote:
XML,
Text |
RIS
Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer.
International journal of molecular sciences 22(3), 1189 (2021) [10.3390/ijms22031189]
BibTeX |
EndNote:
XML,
Text |
RIS
Comparison Of Observation-Based And Model-Based Identification Of Alert Concentrations From Concentration-Expression Data.
Bioinformatics 37(14), 1990-1996 (2021) [10.1093/bioinformatics/btab043]
BibTeX |
EndNote:
XML,
Text |
RIS
Methods and open-source toolkit for analyzing and visualizing challenge results.
Scientific reports 11(1), 2369 (2021) [10.1038/s41598-021-82017-6]
BibTeX |
EndNote:
XML,
Text |
RIS
Comparison of single-scanner single-protocol quantitative ADC measurements to ADC ratios to detect clinically significant prostate cancer.
European journal of radiology 136, 109538 (2021) [10.1016/j.ejrad.2021.109538]
BibTeX |
EndNote:
XML,
Text |
RIS
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma.
Blood cancer journal 11(1), 1 (2021) [10.1038/s41408-020-00390-3]
BibTeX |
EndNote:
XML,
Text |
RIS
Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study.
Cellular immunology 360, 104274 (2021) [10.1016/j.cellimm.2020.104274]
BibTeX |
EndNote:
XML,
Text |
RIS
Interim [18F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma.
European journal of nuclear medicine and molecular imaging 48(6), 1932-1943 (2021) [10.1007/s00259-020-05137-7]
BibTeX |
EndNote:
XML,
Text |
RIS
An R-shiny application to calculate optimal designs for single substance and interaction trials in dose response experiments.
Toxicology letters 337, 18 - 27 (2021) [10.1016/j.toxlet.2020.11.018]
BibTeX |
EndNote:
XML,
Text |
RIS
Comparison of Prostate MRI Lesion Segmentation Agreement Between Multiple Radiologists and a Fully Automatic Deep Learning System.[Vergleich der Kongruenz von Prostata-MRT-Läsionssegmentationen durch mehrere Radiologen und ein vollautomatisches Deep-Learning-System].
Ro?Fo 193(5), 559-573 (2021) [10.1055/a-1290-8070]
BibTeX |
EndNote:
XML,
Text |
RIS
On relationships between the Pearson and the distance correlation coefficients
Statistics & probability letters 169, 108960 (2021) [10.1016/j.spl.2020.108960]
BibTeX |
EndNote:
XML,
Text |
RIS
Measured Multipoint Ultra-High b-Value Diffusion MRI in the Assessment of MRI-Detected Prostate Lesions.
Investigative radiology 56(2), 94-102 (2021) [10.1097/RLI.0000000000000712]
BibTeX |
EndNote:
XML,
Text |
RIS
Comments on 'Incorporating historical two-arm data in clinical trials with binary outcome: A practical approach' by Manuel Feißt, Johannes Krisam and Meinhard Kieser.
Pharmaceutical statistics 20(1), 196-198 (2021) [10.1002/pst.2061]
BibTeX |
EndNote:
XML,
Text |
RIS
Re: The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
European urology 79(1), 164-165 (2021) [10.1016/j.eururo.2020.08.019]
BibTeX |
EndNote:
XML,
Text |
RIS
Diagnostic accuracy of 18F-PSMA-1007-PET/CT imaging for lymph node staging of prostate carcinoma in primary and biochemical recurrence.
Journal of nuclear medicine 62(2), 208-213 (2021) [10.2967/jnumed.120.246363]
BibTeX |
EndNote:
XML,
Text |
RIS
Simulated clinical deployment of fully automatic deep learning for clinical prostate MRI assessment.
European radiology 31(1), 302-313 (2021) [10.1007/s00330-020-07086-z]
Fulltext
BibTeX |
EndNote:
XML,
Text |
RIS
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age.
Leukemia 35(3), 809-822 (2021) [10.1038/s41375-020-0976-9]
BibTeX |
EndNote:
XML,
Text |
RIS
Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE.
Leukemia 35(4), 1134-1144 (2021) [10.1038/s41375-020-0948-0]
BibTeX |
EndNote:
XML,
Text |
RIS
Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography-fusion Biopsy.
European urology focus 7(6), 1300-1307 (2021) [10.1016/j.euf.2020.06.020]
BibTeX |
EndNote:
XML,
Text |
RIS
Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer.
European journal of nuclear medicine and molecular imaging 48(1), 143-151 (2021) [10.1007/s00259-020-04777-z]
BibTeX |
EndNote:
XML,
Text |
RIS
Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panel.
Haematologica 106(2), 446-453 (2021) [10.3324/haematol.2019.238790]
BibTeX |
EndNote:
XML,
Text |
RIS
Equilibrium radionuclide angiography: Intra- and inter-observer repeatability and reproducibility in the assessment of cardiac systolic and diastolic function.
Journal of nuclear cardiology 28(4), 1304-1314 (2021) [10.1007/s12350-019-01830-9]
BibTeX |
EndNote:
XML,
Text |
RIS